Inhibition of in vivo and in vitro fertilization in rodents by gonadotropin-releasing hormone antagonists

Biology of Reproduction

Volumn 67, Issue 4, 2002, Pages 1360-1365

  Morales, Patricio ^a   Pasten, Consuelo ^a   Pizarro, Eduardo ^a  

^a UNIVERSIDAD DE ANTOFAGASTA   (Chile)

Author keywords

Female reproductive tract; Fertilization; Gamete biology; Gonadotropin releasing hormone; Sperm motility and transport

Indexed keywords

GONADORELIN; GONADORELIN ANTAGONIST;

ACROSOME; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FEMALE; FERTILIZATION; NONHUMAN; OVIDUCT; OVULATION; PRIORITY JOURNAL; PROESTRUS; RAT; SPERMATOZOON MIGRATION; SPERMATOZOON MOTILITY; ZONA PELLUCIDA;

ANIMALIA; RODENTIA;

EID: 0036786781     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod67.4.1360     Document Type: Article

References (40)

1. Wassarman PM. Zona pellucida glycoproteins. Annu Rev Biochem 1988; 57:414-442.
2. Yanagimachi R. Mammalian fertilization. In: Knobil E, Neill JD (eds.), The Physiology of Reproduction. New York: Raven Press; 1994: 189-317.
3. Morales P, Llanos MN. Human sperm interaction with the zona pellucida and the mechanism of the acrosome reaction. Front Biosci 1996; 1:146-160.
4. Morales P. Gonadotropin-releasing hormone increases ability of the spermatozoa to bind to the human zona pellucida. Biol Reprod 1998; 59:426-430.
5. Conn PM, Huckle WR, Andrews WV, McArdle CA. The molecular mechanism of action of gonadotropin releasing hormone (GnRH) in the pituitary. Recent Prog Horm Res 1987; 43:29-68.
6. Ying S-Y, Ling N, Bohlen P, Guillemin R. Gonadocrinins: peptides in ovarian follicular fluid stimulating the secretion of pituitary gonadotropins. Endocrinology 1981; 108:1206-1215.
7. Izumi S-I, Makino T, Iizuka R. Immunoreactive luteinizing hormone-releasing hormone in the seminal plasma and human semen parameters. Fertil Steril 1985; 43:617-620.
8. Sokol RZ, Peterson M, Heber D, Swerdloff RS. Identification and partial characterization of gonadotropin-releasing hormone-like factors in human seminal plasma. Biol Reprod 1985; 33:370-374.
9. Casañ EM, Raga F, Kruessel JS, Wen Y, Nezhat C, Polan ML. Immunoreactive gonadotropin-releasing hormone expression in cycling human endometrium of fertile patients. Fertil Steril 1998; 70:102-106.
10. Casañ EM, Raga F, Bonilla-Musoles F, Polan ML. Human oviductal gonadotropin-releasing hormone: possible implications in fertilization, early embryonic development, and implantation. J Clin Endocrinol Metab 2000; 85:1377-1381.
11. Iwashita M, Catt KJ. Photoaffinity labeling of pituitary and gonadal receptors for gonadotropin-releasing hormone. Endocrinology 1985; 117:738-746.
12. Petersson F, Emons G, Hammar M. Testicular GnRH-receptors and direct effects of a GnRH-agonist on human testicular steroidogenesis. Scand J Urol Nephrol 1989; 23:161-164.
13. Lee CYG, Ho J, Chow SN, Yasojima K, Schwab C, McGeer PL. Immunoidentification of gonadotropin releasing hormone receptor in human sperm, pituitary and cancer cells. Am J Reprod Immunol 2000; 44:170-177.
14. Bull P, Morales P, Huyser C, Socfas T, Castellón E, Expression of gonadotropin-releasing hormone receptor in mouse and rat testicular germ cells. Mol Hum Reprod 2000; 6:582-586.
15. Funston RN, Seidel GE. Gonadotropin-releasing hormone increases cleavage rates of bovine oocytes fertilized in vitro. Biol Reprod 1995; 53:541-545.
16. Morales P, Kerr B, Oliva C, Pizarro E, Kong M. Gonadotropin-releasing hormone antagonists inhibit sperm binding to the human zona pellucida. Hum Reprod 1999; 14:2069-2074.
17. Forcelledo ML, Morales P, Vera R, Quijada S, Croxatto HB. The role of ovarian and adrenal progesterone in the regulation of ovum transport in pregnant rats. Biol Reprod 1982; 27:1033-1041.
18. Martin MJ. Development of in vivo-matured porcine oocytes following intracytoplasmic sperm injection. Biol Reprod 2000; 63:109-112.
19. Smith TT, Yanagimachi R. The viability of hamster spermatozoa stored in the isthmus of the oviduct: the importance of sperm-epithelium contact for sperm survival. Biol Reprod 1990; 42:450-457.
20. Orihuela PA, Ortiz ME, Croxatto HB. Sperm migration into and through the oviduct following artificial insemination at different stages of the estrous cycle in the rat. Biol Reprod 1999; 60:908-913.
21. Quinn P, Barros C, Whittingham DG. Preservation of hamster oocytes to assay the fertilizing capacity of human spermatozoa. J Reprod Fertil 1982; 66:161-168.
22. Whittingham DG. Culture of mouse ova. J Reprod Fertil 1971; 14:7-12.
23. Larson JL, Miller DJ. Simple histochemical stain for acrosomes on sperm from several species. Mol Reprod Dev 1999; 52:445-449.
24. Franken DR, Oehninger SC, Burkman LJ, Coddington CC, Kruger TF, Rosenwaks Z, Acosta AA, Hodgen GD. The hemizona assay (HZA): a predictor of human sperm fertilizing potential in in vitro fertilization (IVF) treatment. J In Vitro Fertil Embryo Transf 1989; 6: 44-50.
25. Shalgi R, Kraicer PF. Timing of sperm transport, sperm penetration and cleavage in the rat. J Exp Zool 1978; 204:353-360.
26. Suarez SS. Sperm transport and motility in the mouse oviduct: observations in situ. Biol Reprod 1987; 36:203-210.
27. Hernandez ER. Embryo implantation. The rubicon for GnRH antagonists. Hum Reprod 2000; 15:1211-1216.
28. Morales P, Pizarro E, Kong M, Kerr B, Ceric F, Vigil P. Gonadotropin-releasing hormone-stimulated sperm binding to the human zona is mediated by a calcium influx. Biol Reprod 2000; 63:635-642.
29. Danforth DR, Williams RF, Gordon K, Leal JA, Hodgen GD. Inhibition of pituitary gonadotropin secretion by the gonadotropin-releasing hormone antagonist antide. II. Development of an in vitro bioassay for characterization of pharmacokinetics and pharmacodynamics of antide in circulation. Endocrinology 1991; 128:2041-2044.
30. Gordon K, Williams RF, Danforth DR, Hodgen GD. Antide-induced suppression of pituitary gonadotropin and ovarian steroid secretion in cynomolgus monkeys: premature luteolysis and prolonged inhibition of folliculogenesis following single treatment. Biol Reprod 1991; 44: 701-706.
31. Gordon K, Williams RF, Danforth DR, Conn PM, Hutchison JS, Hodgen GD. Suppression of ovarian estradiol secretion by a single injection of antide in cynomolgus, monkeys during the early follicular phase: immediate, sustained, and reversible actions. J Clin Endocrinol Metab 1991; 73:1262-1268.
32. Loumaye E, Coen G, Pampfer S, Vankrieken L, Thomas K. Use of a gonadotropin-releasing hormone agonist during ovarian stimulation leads to significant concentrations of peptide in follicular fluids. Fertil Steril 1989; 52:256-263.
33. Yano T, Yano N, Matsumi H, Morita Y, Tsutsumi O, Schally AV, Taketani Y. Effect of luteinizing hormone-releasing hormone analogs on the rat ovarian follicle development. Horm Res 1997; 48:35-41.
34. Chatzistamou I, Schally AV, Szepeshazi K, Groot K, Hebert F, Arencibia JM. Inhibition of growth of ES-2 human ovarian cancers by bombesin antagonist RC-3095, and luteinizing hormone-releasing hormone antagonist cetrorelix. Cancer Lett 2001; 171:37-45.
35. Emons G, Muller V, Ortmann O, Schulz KD. Effects of LHRH-analogues on mitogenic signal transduction in cancer cells. J Steroid Biochem Mol Biol 1998; 65:199-206.
36. Gründker C, Volker P, Schulz KD, Emons G. Luteinizing hormone-releasing hormone agonist triptorelin and antagonist cetrorelix inhibit EGF-induced c-fos expression in human gynecological cancers. Gynecol Oncol 2000; 78:194-202.
37. Jungwirth A, Schally AV, Halmos G, Groot K, Szepeshazi K, Pinski J, Armatis P. Inhibition of the growth of Caki-I human renal adenocarcinoma in vivo by luteinizing hormone-releasing hormone antagonist Cetrorelix, somatostatin analog RC-160, and bombesin antagonist RC-3940-II. Cancer 1998; 82:909-17.
38. Limonta P, Montagnani Marelli M, Moretti RM. LHRH analogues as anticancer agents: pituitary and extrapituitary sites of action. Expert Opin Invest Drugs 2001; 10:709-720.
39. I-mediated activation of phosphotyrosine phosphatase. Endocrinology 2001; 142:2369-2380.
40. Grundker C, Gunther AR, Wesphalen S, Emons G. Biology of the gonadotropin-releasing hormone system in gynecological cancers. Eur J Endocrinol 2002; 146:1-14.